Life Sciences in the Middle East and North Africa
Bloomberg BNA: Life Sciences Law & Industry Report
February 8, 2013
The growth in demand for sophisticated pharmaceutical products in the Middle East and North Africa (MENA) region as witnessed in recent years shows no sign of abating. Increased wealth, spurred by a liberalization of trade policies and the rise in oil and gas prices, has led to irreversible changes in the region’s lifestyle and nutritional habits, and with it, a rise in the prevalence of lifestyle-related ailments and a corresponding demand
for appropriate medicines.
While a number of not-insignificant obstacles to doing business in the region remain, improving sociodemographics, a continued preference for branded drugs, oft-found visionary leadership, improvements in the regulatory environment, and incentives offered to attract multinationals point towards a positive outlook for the life-sciences sector in the MENA region. To learn more, download the full article.